⌘K

Home/Filings/4/0001048477-25-000009

4//SEC Filing

Burkhart Erin 4

Accession 0001048477-25-000009

CIK 0001048477other

View on SEC.gov Company Profile

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 8:21 PM ET

Size

4.7 KB

Accession

0001048477-25-000009

Insider Transaction Report

Form 4

Period: 2025-02-24

BIOMARIN PHARMACEUTICAL INCBMRN

GVP, Chief Accounting Officer

Transactions

Sale
Common Stock
2025-02-24$68.38/sh−1,344$91,903→ 13,105 total

Footnotes (1)

[F1]Trade made pursuant to a 10b5-1 plan executed on November 26, 2024.

Documents

1 file

4
wk-form4_1740532872.xmlPrimary
FORM 4

Issuer

BIOMARIN PHARMACEUTICAL INC

CIK 0001048477

Entity typeother

Related Parties

1

filerCIK 0001927648

Filing Metadata

Form type: 4
Filed: Feb 24, 7:00 PM ET
Accepted: Feb 25, 8:21 PM ET
Size: 4.7 KB

View on SEC.gov